Carregant...
Chemoresistance in ovarian cancer: exploiting cancer stem cell metabolism
Ovarian cancer is most deadly gynecologic malignancies worldwide. Chemotherapy is the mainstay treatment for ovarian cancer. Despite the initial response is promising, frequent recurrence in patients with advanced diseases remains a therapeutic challenge. Thus, understanding the biology of chemoresi...
Guardat en:
| Publicat a: | J Gynecol Oncol |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5823988/ https://ncbi.nlm.nih.gov/pubmed/29468856 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3802/jgo.2018.29.e32 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|